Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 2
2007 1
2008 2
2009 2
2011 2
2012 2
2013 7
2014 3
2015 1
2016 4
2017 5
2018 8
2019 7
2020 9
2021 7
2022 13
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
Martinelli V, Albanese M, Altieri M, Annovazzi P, Arabi S, Bucello S, Caleri F, Cerqua R, Costanzi C, Cottone S, Dalla Costa G, Direnzo V, Fantozzi R, Favaretto A, Lorefice L, Montini F, Noce A, Plewnia K, Repice AM, Sacco R, Vecchio D. Martinelli V, et al. Among authors: annovazzi p. Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):935-946. doi: 10.26355/eurrev_202202_28003. Eur Rev Med Pharmacol Sci. 2022. PMID: 35179760 Free article. Review.
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
Schiavetti I, Cordioli C, Stromillo ML, Teresa Ferrò M, Laroni A, Cocco E, Cola G, Pasquali L, Rilla MT, Signoriello E, Iodice R, Di Sapio A, Lanzillo R, Caleri F, Annovazzi P, Conte A, Liberatore G, Ruscica F, Docimo R, Bonavita S, Ulivelli M, Cavalla P, Patti F, Ferraro D, Clerico M, Immovilli P, Di Filippo M, Salvetti M, Sormani MP. Schiavetti I, et al. Among authors: annovazzi p. Mult Scler. 2022 Nov;28(13):2106-2111. doi: 10.1177/13524585221102918. Epub 2022 Jun 23. Mult Scler. 2022. PMID: 35735030
A Comprehensive Review on Copemyl®.
Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Sormani MP, Ghezzi A. Annovazzi P, et al. Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31. Neurol Ther. 2017. PMID: 28762192 Free PMC article. Review.
Neuropathic cranial pain.
Colombo B, Annovazzi PO, Comi G. Colombo B, et al. Among authors: annovazzi po. Neurol Sci. 2003 May;24 Suppl 2:S132-7. doi: 10.1007/s100720300061. Neurol Sci. 2003. PMID: 12811612 Review.
Medications for neuropathic pain: current trends.
Colombo B, Annovazzi PO, Comi G. Colombo B, et al. Among authors: annovazzi po. Neurol Sci. 2006 May;27 Suppl 2:S183-9. doi: 10.1007/s10072-006-0598-7. Neurol Sci. 2006. PMID: 16688627 Review.
A real-world study of alemtuzumab in a cohort of Italian patients.
Russo CV, Saccà F, Frau J, Annovazzi P, Signoriello E, Bonavita S, Grasso R, Clerico M, Cordioli C, Laroni A, Capobianco M, Torri Clerici V, Sartori A, Cavalla P, Maniscalco GT, La Gioia S, Caleri F, Giugno A, Iodice R, Carotenuto A, Cocco E, Fenu G, Zaffaroni M, Baroncini D, Lus G, Gallo A, De Mercanti SF, Lapucci C, Di Francescantonio V, Brambilla L, Sormani MP, Signori A. Russo CV, et al. Among authors: annovazzi p. Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5. Eur J Neurol. 2022. PMID: 34558755 Free PMC article.
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.
Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP. Saccà F, et al. Among authors: annovazzi p. Mult Scler. 2019 Aug;25(9):1263-1272. doi: 10.1177/1352458518790390. Epub 2018 Jul 25. Mult Scler. 2019. PMID: 30044207 Free article.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Maniscalco GT, Saccà F, Lanzillo R, Annovazzi P, Baroncini D, Binello E, Repice A, Perini P, Clerico M, Mataluni G, Bonavita S, La Gioia S, Gutierrez LP, Laroni A, Frau J, Cocco E, Torri Clerici V, Zarbo IR, Sartori A, Signoriello E, Rasia S, Cordioli C, Stromillo ML, Cerqua R, Pontecorvo S, Di Sapio A, Grasso R, Barone S, Lavorgna L, Barrilà C, Landi D, Russo CV, Frigeni B, Ippolito D, Turano G, Carmisciano L, Sormani MP, Signori A. Maniscalco GT, et al. Among authors: annovazzi p. Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16. Mult Scler Relat Disord. 2020. PMID: 32208344
72 results